Scientists Create New Family of 'Super-antibiotics' That can Effectively Treat MRSA

Scientists have developed a family of 'super-antibiotics' which can effectively treat MRSA and other deadly infections.

During the study, one of the drugs killed strains of the hospital superbug resistant to antibiotics already in use.

MRSA “Super bug” – Symptoms - Risk Factors – Diagnosis - Treatment
MRSA infection is the most dreaded hospital or community acquired infection that can become life-threatening.

Others were more than a match for food poisoning bug E coli, and acinetobacter, a soil-dwelling bug that is even harder to treat than MRSA.

New treatments could save the taxpayer millions, as well as save lives.

The 'super-antibiotics' work in a similar way to members of a long-standing family of drugs called quinolones, which tackle respiratory and other infections by interfering with an enzyme that many different types of bacteria need to breed.

'Super Bugs' Gaining Upper Hand Since Antibiotic Arsenal Is Running Out Of Options
More and more people are getting affected by the super bugs as our antibiotic arsenal is running out of options to fight ever-changing bacteria, warn researchers.

The new drugs, still in development stage, attach to the same enzyme as quinolones, but in a different place, meaning they can kill bugs that are resistant to other drugs.

"This is an important step forward in the race against antibiotic resistance," The Daily Mail quoted Ted Bianco, of the Wellcome Trust, as saying.

Super Bugs a Major Public Health Challenge: EU Health Commissioner
Multi-drug resistant "super bugs" are one of the major challenges for public health in Europe, with action required both at a national and EU-wide level, EU Health Commissioner Androulla

Source-ANI

Drug-resistant Super Bugs may Arise from Broad Spectrum Antibiotics
University of Melbourne researchers suggest that doctors avoid prescribing expensive broad-spectrum antibiotics for pneumonia to avoid the development of more drug-resistant super bugs.